Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,084 public trials 2,045 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation

NCT00925782

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Kansas Medical Center/University of Kansas Cancer Center and Medical Pavillion Kansas City, Kansas, United States

View Trial Details

Completed

Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome

NCT00001852

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +22 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

NCT00001637

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +25 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Patient Preference for Pegfilgrastim (Neulasta®) Application Forms

NCT03619993

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Research Site Aschaffenburg, Germany

Research Site Augsburg, Germany

Research Site Berlin, Germany

Research Site Bonn, Germany

View all 48 locations

View Trial Details

Completed

The Second Multicenter Hemophilia Cohort Study

NCT00341705

Conditions: Acquired Immunodeficiency Syndrome, Adenocarcinoma, Blood Coagulation Disorders, +46 more
Locations: University of Arizona Tucson, Arizona, United States

University of California, Davis Davis, California, United States

Children's Hospital of Orange County Orange, California, United States

University of California, San Francisco San Francisco, California, United States

View all 48 locations

View Trial Details

Completed

ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer

NCT01445522

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: City of Hope National Medical Center Duarte, California, United States

National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

NCT02958969

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma

NCT00581776

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University Of Wisconsin Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00450814

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

NCT01326702

Conditions: Adult B Acute Lymphoblastic Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Solid Neoplasm, +88 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions